Three-year outcomes in kidney transplant recipients switched from calcineurin inhibitor-based regimens to belatacept as a rescue therapy

HIGHLIGHTS

• who: CNI and colleagues from the (UNIVERSITY) have published the research work: Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy, in the Journal: (JOURNAL) of August/30,/2021
• what: The authors assessed the safety and tolerability of belatacept treatment as a rescue therapy up to 3 years after switching from CNIs. One of the main reasons is the growing proportion of expanded criteria donors (ECD) in kidney transplantation (KT) .

SUMMARY

The authors analyzed kidney allograft function, patient and kidney allograft . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.